FdaApplication

ANDA 205936

Back to search

Identifiers

Properties

PropertyValue
applicant_nameZYDUS PHARMACEUTICALS USA INC
application_typeANDA
approval_date2018-07-18

Products (3)

ProductActive ingredientStrengthDosage form
SPIRONOLACTONESPIRONOLACTONE100MGTABLET;ORAL
SPIRONOLACTONESPIRONOLACTONE50MGTABLET;ORAL
SPIRONOLACTONESPIRONOLACTONE25MGTABLET;ORAL

3 products